| Spokesperson | |
| • | Professor Alfredo Alberti, Padova, Italy Overview and Welcome Where We Are with HCV Treatment Today |
| • | Associate Professor Mark Sulkowski, Baltimore, MD, USA In Initial Therapy: Clinical Differences between the Current Treatment Regimens and Implications for Patient Outcome |
| • | Professor Thierry Poynard, Paris, France In Retreatment with Peglntron: The Importance of Patient Selection and the Week 12 Response for a Second Chance at SVR |
| • | Professor Stefan Zeuzem, Frankfurt a. M., Germany Implications for the Future of HCV Treatment |
| Useful documents & links: | |
|
Need help? Ask our technical people: *You must have Flash Player and the JAVA plugin to join this webcast. |
|
